Published in Immunobiology on March 01, 1987
Ex vivo characterization and isolation of rare memory B cells with antigen tetramers. Blood (2011) 1.21
Purified mu EBP-E binds to immunoglobulin enhancers and promoters. Mol Cell Biol (1988) 1.09
XBP-1-deficient plasmablasts show normal protein folding but altered glycosylation and lipid synthesis. J Immunol (2009) 1.02
Kappa immunoglobulin promoters and enhancers display developmentally controlled interactions. Nucleic Acids Res (1993) 1.01
A developmentally modulated chromatin structure at the mouse immunoglobulin kappa 3' enhancer. Mol Cell Biol (1996) 1.01
Lipopolysaccharide and dexamethasone induce mouse mammary tumor proviral gene expression and differentiation in B lymphocytes through distinct regulatory pathways. Mol Cell Biol (1990) 1.00
Characterization of a presecretory phase in B-cell differentiation. Proc Natl Acad Sci U S A (1989) 0.97
Cross talk between immunoglobulin heavy-chain transcription and RNA surveillance during B cell development. Mol Cell Biol (2011) 0.86
Selective synergy of immunoglobulin enhancer elements in B-cell development: a characteristic of kappa light chain enhancers, but not heavy chain enhancers. Nucleic Acids Res (1994) 0.83
Anti-IgM antibodies down modulate mu-enhancer activity and OTF2 levels in LPS-stimulated mouse splenic B-cells. Nucleic Acids Res (1991) 0.82
Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell (1993) 11.95
Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature (1991) 5.51
Replacement of T-cell function by a T-cell product. Nat New Biol (1972) 5.20
A third signal in B cell activation given by TRF. Transplant Rev (1975) 2.18
Immunopathology of interleukin (IL) 2-deficient mice: thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene. J Exp Med (1995) 1.70
Normal clonal expansion but impaired Fas-mediated cell death and anergy induction in interleukin-2-deficient mice. Eur J Immunol (1995) 1.62
Control of T cell hyperactivation in IL-2-deficient mice by CD4(+)CD25(-) and CD4(+)CD25(+) T cells: evidence for two distinct regulatory mechanisms. Eur J Immunol (2001) 1.55
Stimulation of IgG antibody response in vitro by T cell-replacing factor. J Exp Med (1973) 1.55
The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules. J Exp Med (1997) 1.55
Inhibition of in vitro immune response by treatment of spleen cell suspensions with anti-theta serum. Nature (1970) 1.53
Reconstitution of a thymus cell-deprived immune system by syngeneic and allogeneic thymocytes in vitro. Eur J Immunol (1971) 1.47
Cyanamide Formation under Primitive Earth Conditions. Science (1965) 1.42
RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A. EMBO J (1995) 1.34
The differentiation function of T cell-replacing factor in nu-nu spleen cell cultures. Eur J Immunol (1974) 1.33
Autoradiographic studies on the proliferation of antibody-producing cells in vitro. J Exp Med (1974) 1.20
Partial characterization and purification of murine T cell-replacing factor, TRF. II. Biochemical characteristics. Immunochemistry (1978) 1.20
Tumor necrosis factor amplifies measles virus-mediated Ia induction on astrocytes. Proc Natl Acad Sci U S A (1987) 1.18
Expression of MuLV GP71-like antigen in normal mouse spleen cells induced by antigenic stimulation. Nature (1977) 1.18
Studies on the generation and expression of H-2-controlled T helper function in chimeric mice: evidence for two levels of H-2 resitriction. Eur J Immunol (1979) 1.16
Low-grade B cell lymphomas of mucosa-associated lymphoid tissue (MALT-type) require CD40-mediated signaling and Th2-type cytokines for in vitro growth and differentiation. Am J Pathol (1997) 1.15
The interleukin 2 receptor alpha chain/CD25 promoter is a target for nuclear factor of activated T cells. J Exp Med (1998) 1.07
Retarded thymic involution and massive germinal center formation in NF-ATp-deficient mice. Eur J Immunol (1998) 1.07
Blimp-1 overcomes the block in IgM secretion in lipopolysaccharide/anti-mu F(ab')2-co-stimulated B lymphocytes. Eur J Immunol (1996) 1.07
Action of dextran sulfate as a direct and general B cell mitogen. Eur J Immunol (1974) 1.07
Inducible nuclear factors binding the IgM heavy chain pre-mRNA secretory poly(A) site. Eur J Immunol (1996) 1.05
Downregulation of HLA class I antigens in HIV-1-infected cells. AIDS Res Hum Retroviruses (1989) 1.05
Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune-type disorders in mice. J Exp Med (1997) 1.04
NF-ATp plays a prominent role in the transcriptional induction of Th2-type lymphokines. Immunol Lett (1997) 1.01
CD40, but not lipopolysaccharide and anti-IgM stimulation of primary B lymphocytes, leads to a persistent nuclear accumulation of RelB. J Immunol (1996) 1.01
Stimulation of murine B cells with anti-Ig antibodies: dominance of a negative signal mediated by the Fc receptor. Eur J Immunol (1980) 1.00
A1 expression is stimulated by CD40 in B cells and rescues WEHI 231 cells from anti-IgM-induced cell death. Eur J Immunol (1999) 1.00
Kinetics of cellular oncogene expression in mouse lymphocytes. II. Regulation of c-fos and c-myc gene expression. Eur J Immunol (1987) 1.00
Cyclosporin A interferes with the inducible degradation of NF-kappa B inhibitors, but not with the processing of p105/NF-kappa B1 in T cells. Eur J Immunol (1997) 0.98
Properties of mouse leukemia viruses. XVII. Factors required for successful treatment of spontaneous AKR leukemia by antibodies against gp71. Virology (1981) 0.98
Thymic selection and peptide-induced activation of T cell receptor-transgenic CD8 T cells in interleukin-2-deficient mice. Eur J Immunol (1994) 0.97
Properties of mouse leukemia viruses. XIII. Serum therapy of virus-induced murine leukemias. Virology (1976) 0.94
The role of accessory cells in polyclonal T cell activation. I. Both induction of interleukin 2 production and of interleukin 2 responsiveness by concanavalin A are accessory cell dependent. Eur J Immunol (1983) 0.94
Studies on the source and action of the T-cell replacing factor (TRF). Adv Exp Med Biol (1973) 0.94
IgM RNA switch from membrane to secretory form is prevented by adding antireceptor antibody to bacterial lipopolysaccharide-stimulated murine primary B-cell cultures. Proc Natl Acad Sci U S A (1985) 0.94
Blimp-1 over-expression abrogates IL-4- and CD40-mediated suppression of terminal B cell differentiation but arrests isotype switching. Eur J Immunol (2001) 0.94
T cell subset distribution and B cell hyperreactivity in mice expressing interleukin-4 under the control of major histocompatibility complex class I regulatory sequences. Eur J Immunol (1994) 0.93
Regulation of IL 2 expression in mitogen-activated murine T lymphocytes. Immunobiology (1987) 0.92
C/EBPbeta enhances IL-4 but impairs IL-2 and IFN-gamma induction in T cells. Eur J Immunol (2000) 0.92
Effect of inactivation by hydroxylamine on early functions of poliovirus. J Virol (1971) 0.91
Early phenotypic and functional alterations in lymphocytes from simian immunodeficiency virus infected macaques. Vet Immunol Immunopathol (1993) 0.90
Early functions of poliovirus. I. The inhibition of cellular protein synthesis in HeLa cells after infection with active and inactivated poliovirus. Z Naturforsch B (1971) 0.90
Reversal of Blimp-1-mediated apoptosis by A1, a member of the Bcl-2 family. Eur J Immunol (1999) 0.89
A T-cell -produced mediator substance active in the humoral immune response. Ann N Y Acad Sci (1975) 0.89
Overexpression of the antiapoptotic protein A1 promotes the survival of double positive thymocytes awaiting positive selection. Cell Death Differ (2005) 0.88
In vitro immunization of naive mouse B cells: establishment of IgM secreting hybridomas specific for souble protein or hapten from B cells cultured on CD40 ligand transfected mouse fibroblasts. Int Immunol (1996) 0.86
Early functions of poliovirus. 3. The effect of guanidine on early functions. Z Naturforsch B (1971) 0.84
HIV type 1 abrogates TAP-mediated transport of antigenic peptides presented by MHC class I. Transporter associated with antigen presentation. AIDS Res Hum Retroviruses (2002) 0.83
Regulation of lymphokine expression in T cell activation. I. Rapid loss of interleukin-specific RNA after removal of the stimulating signal. Eur J Immunol (1991) 0.83
High yields of DNA-transfer into mouse L-cells by electropermeabilization. Z Naturforsch C (1986) 0.82
Impaired survival of T cell receptor V gamma 3+ cells in interleukin-4 transgenic mice. Eur J Immunol (1995) 0.82
Regulation of Ig gene expression in normal lymphocytes. I. The half-life of secreted mu chain mRNA differs from that of membrane mu chain mRNA in resting and activated B cells. Eur J Immunol (1990) 0.82
Behaviour-associated alopecia areata in mice. Lab Anim (1986) 0.80
Systemic autoimmune disease as a consequence of defective lymphocyte death. Curr Opin Immunol (1997) 0.80
Expression of endogenous viral antigens during immune response. Med Microbiol Immunol (1977) 0.80
Regulation of immunoglobulin gene expression in normal lymphocytes. II. Mechanisms of down-regulation of immunoglobulin secretion after engagement of the B cell antigen receptor. Eur J Immunol (1992) 0.80
Expression of endogenous retroviral glycoprotein 70 by antigen-activated cytotoxic and suppressor T lymphocytes of nice. Proc Natl Acad Sci U S A (1982) 0.79
Inefficient termination of antigen responses in NF-ATp-deficient mice. Immunobiology (1997) 0.79
Time course of lectin and storage protein biosynthesis in developing pea (Pisum sativum) seeds. Biol Chem Hoppe Seyler (1993) 0.78
Kinetics of cellular oncogene expression in mouse lymphocytes. I. Expression of c-myc and c-ras-Ha in T lymphocytes induced by various mitogens. Eur J Immunol (1986) 0.78
A modified absorption-reduction method to detect virus-specific hemagglutination inhibiting and neutralizing IgM antibodies. Med Microbiol Immunol (1981) 0.77
Quantitative and qualitative differences in IL-2 and IL-4 expression in primary and secondary T cell stimulation. Int Immunol (1992) 0.77
Mechanism of MHC class I downregulation in HIV infected cells. Immunobiology (1992) 0.77
Impaired thymopoietic potential of immature CD3(-)CD4(+)CD8(-) T cell precursors from SIV-infected rhesus monkeys. Int Immunol (1999) 0.77
Lymphokines active in B cell proliferation and differentiation. Springer Semin Immunopathol (1984) 0.77
Direct inhibition of protein synthesis and its effect upon the growth of RNA viruses. Ann N Y Acad Sci (1965) 0.76
In vitro skewing of TCR transgenic CD4+ T cells from interleukin-2 deficient mice towards Th1 and Th2 in the absence of exogenous interleukin-2. Eur Cytokine Netw (1998) 0.76
IL-2 receptor alpha-chain expression is independently regulated in primary and secondary lymphoid organs. J Immunol (1998) 0.76
Inhibition of T cell/B cell interaction by B-CLL cells. Leukemia (1999) 0.75
[B cell activation and the humoral immune reaction]. Verh Dtsch Ges Inn Med (1987) 0.75